Stay updated on LessFrequent IV Dosing & TME Study of Nemvaleukin Alfa Clinical Trial
Sign up to get notified when there's something new on the LessFrequent IV Dosing & TME Study of Nemvaleukin Alfa Clinical Trial page.

Latest updates to the LessFrequent IV Dosing & TME Study of Nemvaleukin Alfa Clinical Trial page
- Check5 days agoChange DetectedA new revision entry v3.6.4 is added to the Study Record Versions, replacing v3.6.3 in the history, signaling a small update to the page history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry (v3.6.3) was added to the study record history, superseding the previous v3.6.2, representing an update to the record's metadata rather than changes to the study details.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, reflecting a new version of the record history page. This change only updates the metadata/version tag and does not alter study data or visible content beyond the tag.SummaryDifference0.1%

- Check48 days agoChange DetectedRecruitment is now closed to participants, as shown by the addition 'No longer looking for participants'. The record also adds revision tag v3.6.0 and removes the prior revision v3.5.5.SummaryDifference0.4%

- Check55 days agoChange DetectedThe page history now reflects the new site revision v3.5.5, replacing the previous v3.5.4. This indicates a maintenance release and does not modify the study data or the history it presents.SummaryDifference0.1%

- Check77 days agoChange DetectedThe revision history shows the version updated from v3.5.3 to v3.5.4, indicating a deployment/update of the page. The content and data remain unchanged.SummaryDifference0.1%

Stay in the know with updates to LessFrequent IV Dosing & TME Study of Nemvaleukin Alfa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LessFrequent IV Dosing & TME Study of Nemvaleukin Alfa Clinical Trial page.